Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > History will tell you, this is the time to.....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Bigboyoneon Aug 05, 2016 11:47am
81 Views
Post# 25114126

RE:RE:RE:RE:RE:RE:RE:RE:RE:History will tell you, this is the time to.....

RE:RE:RE:RE:RE:RE:RE:RE:RE:History will tell you, this is the time to.....I have a few concerns here, and the obvious ones are 1. Will Yosprala pass FDA? Its not a given and the stock price surely isnt giving me an indicator. 2. Competition, in the market place. What makes anyone sure someone else doesnt come out with a cheaper and better answer then Yosprala 3. Will the consumer add a pill a day to ward away heart trouble? For me a glass of red wine, does me better. 3. Adams has a great track record and thats what I am banking on. Its a matter of not how, but when, are we talking 2017 or 2021?
No one really believes that earlier this week, the million plus shares that traded (even with double counting) was random buyers going long with Aralez.  ...I am just hoping its not the instiutional boys looking for a 25-35c short on 2q earnings day, next week.
Ive seen it all over the years, and I hope I am wrong in every facet of my negativity and we head to the moon. Ive been right alot though..
GLTA 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities